Table 2.
Baseline clinical and demographics characteristics of the study population.
| AGS Exercise Group (10 Patients) | Control Group (10 Patients) | p | |
|---|---|---|---|
| Age (years) | 62.9 ± 9.7 | 54.5 ± 15.5 | 0.1632 |
| Gender (number of males vs. female) | 0 out of 10 | 2 out of 8 | 0.9999 |
| BMI | 23.3 ± 1.7 | 24.8 ± 1.7 | 0.2190 |
| LEG VOLUME (mL) | 2340 ± 239 | 2419 ± 335 | 0.5496 |
| CEAP | 2.7 ± 0.5 | 2.8 ± 0.4 | 0.7481 |
| MAIN SYMTOMPS | |||
| Heaviness (number of patients out of total) | 10 out of 10 | 10 out of 10 | 0.9999 |
| Pain (number of patients out of total) | 10 out of 10 | 10 out of 10 | 0.9999 |
| Swelling (number of patients out of total) | 10 out of 10 | 10 out of 10 | 0.9999 |
| Throbbing (number of patients out of total) | 7 out of 10 | 8 out of 10 | 0.9999 |
| Itching (number of patients out of total) | 6 out of 10 | 7 out of 10 | 0.9999 |
BMI: body mass index, CEAP: clinical classification for venous insufficiency [3]. A question regarding the main symptoms was asked of the patients to tell if specific and characteristic symptoms of CVI (heaviness, pain, swelling, throbbing, itching) were present or not.